RecruitingPhase 4NCT06271707

Stellate Ganglion Block

Left Sided Stellate Ganglion Blocks Impact on the Rate of Post-operative Atrial Fibrillation in Patients Undergoing Thoracic Surgery: A Pilot Study

Sponsor

University of Minnesota

Enrollment

48 participants

Start Date

May 19, 2025

Study Type

INTERVENTIONAL

Conditions

Lobectomy Esophagectomy Pneumonectomy

Summary

The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.

Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is evaluating the stellate ganglion block — a nerve block injected into the neck — for patients undergoing major lung or esophageal surgery. Researchers want to know if blocking this nerve cluster can reduce certain complications or improve recovery after surgery. **You may be eligible if...** - You are between 18 and 85 years old - You are scheduled for esophagectomy (esophagus removal), pneumonectomy (full lung removal), or lobectomy (partial lung removal) **You may NOT be eligible if...** - You have conditions that make regional anesthesia unsafe - You have specific conditions that make a stellate ganglion block unsafe - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.